Memantine

• Description:

  Memantine, an amantadine derivative with some dopaminergic effects, has been proposed as an antiparkinson agent and has may be used to treat moderate to severe Alzheimer's disease. It acts on the glutamatergic system by blocking NMDA receptors.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  179.307

• Molecular Formula:

  C12H21N

• Notes:

  Research use only, not for human use.

• Receptor:

  Endogenous Metabolite

• CAS Number:

  19982-08-2